68镓-DOTATATE PET/CT在检测von Hippel-Lindau病相关肿瘤中的效用
该前瞻性研究纳入36例VHL病患者共73次多模态影像评估,头对头比较68Ga-DOTATATE PET/CT与CT/MRI对胰腺神经内分泌肿瘤及腹内胰腺外肿瘤的检出率。68Ga-DOTATATE PET/CT在所有解剖部位病变检出上显著优于CT,与MRI相比呈相似趋势,对胰腺病变检出率与解剖影像相当。作者认为鉴于其更高准确性和更低辐射暴露,其在VHL相关病变监测中的潜在作用应进一步研究。
要点
- 68Ga-DOTATATE PET/CT每次扫描检出病灶3.4±0.1个,高于CT的3.2±0.1个(p=0.02)。
- 与MRI比较为2.8±0.1个/次扫描(p=0.03),呈相似趋势。
- 对胰腺病变,68Ga-DOTATATE PET/CT检出率与解剖影像相当。
核心结论
- 68Ga-DOTATATE PET/CT对所有病变的检出率显著高于解剖影像,对VHL患者胰腺病变的检出率与解剖影像相当;鉴于其更高准确性和更低辐射暴露,其在VHL相关病变监测中的潜在作用应进一步研究。
研究设计与样本
- 前瞻性研究的事后分析,纳入确诊VHL病患者36例、共73次多模态影像评估(每位患者2.1±0.8次评估,范围1-4次),对68Ga-DOTATATE PET/CT与CT和/或MRI进行头对头比较。
诊断标准与关键数值
- 68Ga-DOTATATE PET/CT共检出206个病灶(61次扫描),CT检出208个病灶(66次扫描),MRI检出94个病灶(33次扫描)。
临床应用与阅片要点
- 作者认为,鉴于68Ga-DOTATATE PET/CT准确性更高且辐射暴露更低,其在VHL相关病变监测中的潜在作用应进一步研究。
局限性
- 原文为前瞻性研究的事后分析。
- 原文结论指出68Ga-DOTATATE PET/CT在VHL相关病变监测中的潜在作用应进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Patients with von Hippel-Lindau (VHL) disease may develop various tumors, including neuroendocrine tumors of the pancreas (PNETs) and adrenal, central nervous system and retinal hemangioblastomas, kidney tumors and more. 68Ga-DOTATATE positron emission tomography (PET)/computerized tomography (CT) has been shown to be highly accurate for tumors with cells expressing somatostatin receptors. We aimed to assess the performance of 68Ga-DOTATATE PET/CT in patients with VHL disease.
METHODS: Patients with a diagnosis of VHL were enrolled in a prospective study and underwent surveillance imaging for pancreatic lesions (n = 301). The current analysis includes 73 evaluations with multiple imaging modalities of 36 patients (2.1 ± 0.8 evaluations/patient, range 1-4) for a head-to-head comparison of 68Ga-DOTATATE PET/CT, CT and/or MRI. In this post-hoc analysis we compared the detection rates of various imaging modalities for PNETs and for any extrapancreatic tumors located within the scan field of CT/MRI of the abdomen.
RESULTS: 68Ga-DOTATATE PET/CT detected a total of 206 lesions, CT detected 208 lesions and MRI detected 94 lesions in 61, 66 and 33 scans, respectively. 68Ga-DOTATATE PET/CT (3.4 ± 0.1 per scan) was superior than CT (3.2 ± 0.1 per scan, p = 0.02) with a similar trend when comparing with MRI (2.8 ± 0.1 per scan, p = 0.03) in detecting lesions in any anatomic locations.
CONCLUSIONS: 68Ga-DOTATATE PET/CT had a significantly higher detection rate when compared with anatomic imaging for all lesions, and comparable detection rate for pancreatic lesions in VHL patients. Hence, given the higher accuracy and lower radiation exposure associated with 68Ga-DOTATATE PET/CT, its potential role in the surveillance of VHL-associated lesions should be further studied.
引用
- Shell J, Tirosh A, Millo C, et al. The utility of 68Gallium-DOTATATE PET/CT in the detection of von Hippel-Lindau disease associated tumors. Eur J Radiol. 2018. PMID: 30777201. doi:10.1016/j.ejrad.2018.11.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。